TS
Timothy Shaw
Chief Operating Officer

Timothy Shaw insider trades: Marimed (MRMD) stock buys and sales

Chief Operating Officer, Marimed Last trade Dec 12, 2025 36 Form 4 filings
$0
Sold, last 12 months
0 sales
$5K
Bought, last 12 months
1 buy
5
Open-market trades
since 2023
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Timothy reports to the SEC

Open-market buys and sales

5 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 12, 2025MRMD↑ Buy$5K
Apr 29, 2024MRMD↓ Sell10b5-1$10K
Mar 7, 2024MRMD↓ Sell10b5-1$4K
Oct 27, 2023MRMD↓ Sell10b5-1$11K
Apr 28, 2023MRMD↓ Sell10b5-1$14K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MRMD insiders

Open-market trades in the last 12 months

About Timothy Shaw's insider trades

Timothy Shaw is Chief Operating Officer at Marimed (MRMD). Since Apr 28, 2023, Timothy has reported 1 open-market purchase worth $5K and 4 sales worth $39K on SEC Form 4. In the last 12 months: 1 buy ($5K).

4 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (27 filings), shares withheld for taxes (23 filings), grants and awards (9 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.